Consensus Guides on Stroke Thrombolysis for Anticoagulated Patients from Japan: Application to Other Populations
Kazunori Toyoda, Hiroshi Yamagami, Masatoshi Koga
J Stroke. 2018;20(3):321-331.   Published online 2018 Sep 30     DOI: https://doi.org/10.5853/jos.2018.01788
Citations to this article as recorded by Crossref logo
Impact of Direct Oral Anticoagulant Levels on Functional Independence Following Endovascular Thrombectomy in Patients With Atrial Fibrillation
Shin‐Yi Lin, Yen‐Heng Lin, Chih‐Hao Chen, Chung‐Wei Lee, Yuan‐Chang Chao, Yu‐Fong Peng, Ching‐Hua Kuo, Chih‐Fen Huang, Sung‐Chun Tang, Jiann‐Shing Jeng
Stroke: Vascular and Interventional Neurology.2024;[Epub]     CrossRef
Development and refinement of diagnostic and therapeutic strategies for managing patients with cardiogenic stroke: An arduous journey
Ze-Xin Fan, Ri-Xia Liu, Guang-Zhi Liu
World Journal of Clinical Cases.2023; 11(4): 719.     CrossRef
Standard operating procedure for idarucizumab reversal of dabigatran anticoagulation in ischemic and hemorrhagic stroke
Senta Frol, Janja Pretnar Oblak, Mišo Šabovič, Pawel Kermer
Journal of Thrombosis and Thrombolysis.2023; 55(3): 506.     CrossRef
Safety and efficacy of intravenous thrombolysis in patients with acute ischemic stroke taking direct oral anticoagulants prior to stroke: a meta-analysis
Huo Liang, Xue Wang, Xuemei Quan, Bin Qin, Jian Zhang, Shuolin Liang, Zhijian Liang
Journal of Neurology.2023; 270(9): 4192.     CrossRef
Characteristics and outcomes of unknown onset stroke: The Japan Stroke Data Bank
Shinichi Wada, Sohei Yoshimura, Kazunori Toyoda, Michikazu Nakai, Yusuke Sasahara, Kaori Miwa, Junpei Koge, Akiko Ishigami, Masayuki Shiozawa, Kuniaki Ogasawara, Takanari Kitazono, Shigeru Nogawa, Yoshitaka Iwanaga, Yoshihiro Miyamoto, Kazuo Minematsu, Ma
Journal of the Neurological Sciences.2023; 453: 120798.     CrossRef
Idarucizumab for Emergency Reversal of the Anticoagulant Effects of Dabigatran: Final Results of a Japanese Postmarketing Surveillance Study
Masahiro Yasaka, Hiroyuki Yokota, Michiyasu Suzuki, Hidesaku Asakura, Teiichi Yamane, Yukako Ogi, Takaaki Kimoto, Daisuke Nakayama
Cardiology and Therapy.2023; 12(4): 723.     CrossRef
Intravenous Thrombolysis for Acute Ischemic Stroke in Patients With Recent Direct Oral Anticoagulant Use: A Systematic Review and Meta‐Analysis
Malik Ghannam, Mohammad AlMajali, Milagros Galecio‐Castillo, Abdullah Al Qudah, Farid Khasiyev, Mahmoud Dibas, Dana Ghazaleh, Juan Vivanco‐Suarez, Cristian Morán‐Mariños, Mudassir Farooqui, Aaron Rodriguez‐Calienes, Prateeka Koul, Hannah Roeder, HyungSub
Journal of the American Heart Association.2023;[Epub]     CrossRef
Intravenous Thrombolysis With Alteplase at 0.6 mg/kg in Patients With Ischemic Stroke Taking Direct Oral Anticoagulants
Takashi Okada, Takeshi Yoshimoto, Shinichi Wada, Sohei Yoshimura, Tetsuya Chiba, Shuhei Egashira, Shunsuke Kimura, Masayuki Shiozawa, Manabu Inoue, Masafumi Ihara, Kazunori Toyoda, Hiroshi Takashima, Masatoshi Koga
Journal of the American Heart Association.2022;[Epub]     CrossRef
Acute ischemic stroke management: concepts and controversies.A narrative review
Ka Hou Christien Li, Aaron Jesuthasan, Christopher Kui, Ruth Davies, Gary Tse, Gregory Y. H. Lip
Expert Review of Neurotherapeutics.2021; 21(1): 65.     CrossRef
Recanalisation therapies for acute ischaemic stroke in patients on direct oral anticoagulants
David J Seiffge, Thomas Meinel, Jan Christoph Purrucker, Johannes Kaesmacher, Urs Fischer, Duncan Wilson, Teddy Y Wu
Journal of Neurology, Neurosurgery & Psychiatry.2021; 92(5): 534.     CrossRef
European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke
Eivind Berge, William Whiteley, Heinrich Audebert, GM De Marchis, Ana Catarina Fonseca, Chiara Padiglioni, Natalia Pérez de la Ossa, Daniel Strbian, Georgios Tsivgoulis, Guillaume Turc
European Stroke Journal.2021; 6(1): I.     CrossRef
Acute Stroke Treatment in an Anticoagulated Patient: When Is Thrombolysis an Option?
Teresa Siller, Arvind Chandratheva, Philipp Bücke, David J. Werring, David Seiffge
Current Treatment Options in Neurology.2021;[Epub]     CrossRef
Idarucizumab for Intravenous Thrombolysis and Endovascular Thrombectomy in Acute Stroke: A Case Report
Yu-Ting Lin, Yen-Jun Lai, Tzu-Hsien Lai
The Journal of Emergency Medicine.2020; 58(3): e113.     CrossRef
Safety of Intravenous Thrombolysis Among Patients Taking Direct Oral Anticoagulants
Shima Shahjouei, Georgios Tsivgoulis, Nitin Goyal, Alireza Sadighi, Ashkan Mowla, Ming Wang, David J. Seiffge, Ramin Zand
Stroke.2020; 51(2): 533.     CrossRef
Endovascular Stroke Treatment and Risk of Intracranial Hemorrhage in Anticoagulated Patients
Thomas R. Meinel, Joachim U. Kniepert, David J. Seiffge, Jan Gralla, Simon Jung, Elias Auer, Sebastién Frey, Martina Goeldlin, Pasquale Mordasini, Pascal J. Mosimann, Raul G. Nogueira, Diogo C. Haussen, Gabriel M. Rodrigues, Timo Uphaus, Vincent L’Allinec
Stroke.2020; 51(3): 892.     CrossRef
Acute Ischemic Stroke Outcome and Preceding Anticoagulation: Direct Oral Anticoagulants Versus Vitamin K Antagonists
Sofia Felício Tavares, Inês Ferreira, Vanessa Chaves, Luis Flores, Cristina Correia, Jorge Almeida, Luísa Fonseca, Paulo Castro Chaves
Journal of Stroke and Cerebrovascular Diseases.2020; 29(4): 104691.     CrossRef
Idarucizumab for Emergency Reversal of Anticoagulant Effects of Dabigatran: Interim Results of a Japanese Post-Marketing Surveillance Study
Masahiro Yasaka, Hiroyuki Yokota, Michiyasu Suzuki, Hidesaku Asakura, Teiichi Yamane, Yukako Ogi, Kaori Ochiai, Daisuke Nakayama
Cardiology and Therapy.2020; 9(1): 167.     CrossRef
MRI characteristics in acute ischemic stroke patients with preceding direct oral anticoagulant therapy as compared to vitamin K antagonists
Thomas Raphael Meinel, Johannes Kaesmacher, Jan Gralla, David J. Seiffge, Elias Auer, Sebastién Frey, Marwan El-Koussy, Marcel Arnold, Urs Fischer, Martina Göldlin, Simon Jung, Arsany Hakim
BMC Neurology.2020;[Epub]     CrossRef
Intravenous Thrombolysis in Acute Ischemic Stroke After Idarucizumab Reversal of Dabigatran Effect: Analysis of the Cases From Taiwan
Chen-Wen Fang, Yi-Te Tsai, Ping-Chen Chou, Hsi-Ming Chen, Chien-Ming Lu, Chen-Rong Tsao, Chih-Lin Chen, Mu-Chien Sun, Yu-Song Shih, Cheng-Yang Hsieh, Lu-An Chen, Po-Lin Chen, Jung-Tze Yeh, Yi-Heng Li
Journal of Stroke and Cerebrovascular Diseases.2019; 28(3): 815.     CrossRef
Stroke severity in patients with preceding direct oral anticoagulant therapy as compared to vitamin K antagonists
Elias Auer, Sebastién Frey, Johannes Kaesmacher, Arsany Hakim, David J. Seiffge, Martina Goeldlin, Marcel Arnold, Urs Fischer, Simon Jung, Thomas Raphael Meinel
Journal of Neurology.2019; 266(9): 2263.     CrossRef
Small but Steady Steps in Stroke Medicine in Japan
Kazunori Toyoda, Manabu Inoue, Masatoshi Koga
Journal of the American Heart Association.2019;[Epub]     CrossRef
Multicenter Prospective Analysis of Stroke Patients Taking Oral Anticoagulants: The PASTA Registry - Study Design and Characteristics
Satoshi Suda, Yasuyuki Iguchi, Shigeru Fujimoto, Yoshiki Yagita, Yu Kono, Masayuki Ueda, Kenichi Todo, Tomoyuki Kono, Takayuki Mizunari, Mineo Yamazaki, Takao Kanzawa, Seiji Okubo, Kimito Kondo, Nobuhito Nakajima, Takeshi Inoue, Takeshi Iwanaga, Makoto Na
Journal of Stroke and Cerebrovascular Diseases.2019; 28(12): 104456.     CrossRef
Guidelines for Intravenous Thrombolysis (Recombinant Tissue-type Plasminogen Activator), the Third Edition, March 2019: A Guideline from the Japan Stroke Society
Kazunori TOYODA, Masatoshi KOGA, Yasuyuki IGUCHI, Ryo ITABASHI, Manabu INOUE, Yasushi OKADA, Kuniaki OGASAWARA, Akira TSUJINO, Yasuhiro HASEGAWA, Taketo HATANO, Hiroshi YAMAGAMI, Toru IWAMA, Yoshiaki SHIOKAWA, Yasuo TERAYAMA, Kazuo MINEMATSU
Neurologia medico-chirurgica.2019; 59(12): 449.     CrossRef
Successful thrombolytic therapy with recombinant tissue plasminogen activator in ischemic stroke after idarucizumab administration for reversal of dabigatran: a case report
Toshiyuki Ohtani, Ryosuke Sintoku, Tasuku Yajima, Naoyuki Kaneko
Journal of Medical Case Reports.2019;[Epub]     CrossRef